BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 17987106)

  • 1. Nitric oxide destabilizes Pias3 and regulates sumoylation.
    Qu J; Liu GH; Wu K; Han P; Wang P; Li J; Zhang X; Chen C
    PLoS One; 2007 Oct; 2(10):e1085. PubMed ID: 17987106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity-Induced SUMOylation of Neuronal Nitric Oxide Synthase Is Associated with Plasticity of Synaptic Transmission and Extracellular Signal-Regulated Kinase 1/2 Signaling.
    Du CP; Wang M; Geng C; Hu B; Meng L; Xu Y; Cheng B; Wang N; Zhu QJ; Hou XY
    Antioxid Redox Signal; 2020 Jan; 32(1):18-34. PubMed ID: 31642335
    [No Abstract]   [Full Text] [Related]  

  • 3. Sumoylation of the estrogen receptor alpha hinge region regulates its transcriptional activity.
    Sentis S; Le Romancer M; Bianchin C; Rostan MC; Corbo L
    Mol Endocrinol; 2005 Nov; 19(11):2671-84. PubMed ID: 15961505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The SUMO-E3 ligase PIAS3 targets pyruvate kinase M2.
    Spoden GA; Morandell D; Ehehalt D; Fiedler M; Jansen-Dürr P; Hermann M; Zwerschke W
    J Cell Biochem; 2009 May; 107(2):293-302. PubMed ID: 19308990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein inhibitor of activated STAT3 (PIAS3) protein promotes SUMOylation and nuclear sequestration of the intracellular domain of ErbB4 protein.
    Sundvall M; Korhonen A; Vaparanta K; Anckar J; Halkilahti K; Salah Z; Aqeilan RI; Palvimo JJ; Sistonen L; Elenius K
    J Biol Chem; 2012 Jun; 287(27):23216-26. PubMed ID: 22584572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SUMOylation of Argonaute-2 regulates RNA interference activity.
    Josa-Prado F; Henley JM; Wilkinson KA
    Biochem Biophys Res Commun; 2015 Sep; 464(4):1066-1071. PubMed ID: 26188511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a novel posttranslational modification in neuronal nitric oxide synthase by small ubiquitin-related modifier-1.
    Watanabe M; Itoh K
    Biochim Biophys Acta; 2011 Jul; 1814(7):900-7. PubMed ID: 21545853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a new small ubiquitin-like modifier (SUMO)-interacting motif in the E3 ligase PIASy.
    Kaur K; Park H; Pandey N; Azuma Y; De Guzman RN
    J Biol Chem; 2017 Jun; 292(24):10230-10238. PubMed ID: 28455449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PIAS3 interacts with ATF1 and regulates the human ferritin H gene through an antioxidant-responsive element.
    Iwasaki K; Hailemariam K; Tsuji Y
    J Biol Chem; 2007 Aug; 282(31):22335-43. PubMed ID: 17565989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SUMO E3 ligases are expressed in the retina and regulate SUMOylation of the metabotropic glutamate receptor 8b.
    Dütting E; Schröder-Kress N; Sticht H; Enz R
    Biochem J; 2011 Apr; 435(2):365-71. PubMed ID: 21288202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SUMOylation can regulate the activity of ETS-like transcription factor 4.
    Kaikkonen S; Makkonen H; Rytinki M; Palvimo JJ
    Biochim Biophys Acta; 2010 Aug; 1799(8):555-60. PubMed ID: 20637912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The SUMO (Small Ubiquitin-like Modifier) Ligase PIAS3 Primes ATR for Checkpoint Activation.
    Wu CS; Zou L
    J Biol Chem; 2016 Jan; 291(1):279-90. PubMed ID: 26565033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sumoylation of bZIP transcription factor NRL modulates target gene expression during photoreceptor differentiation.
    Roger JE; Nellissery J; Kim DS; Swaroop A
    J Biol Chem; 2010 Aug; 285(33):25637-44. PubMed ID: 20551322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms in the UBC9 and PIAS3 genes of the SUMO-conjugating system and breast cancer risk.
    Dünnebier T; Bermejo JL; Haas S; Fischer HP; Pierl CB; Justenhoven C; Brauch H; Baisch C; Gilbert M; Harth V; Spickenheuer A; Rabstein S; Pesch B; Brüning T; Ko YD; Hamann U
    Breast Cancer Res Treat; 2010 May; 121(1):185-94. PubMed ID: 19760037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interaction of Piasy with Trim32, an E3-ubiquitin ligase mutated in limb-girdle muscular dystrophy type 2H, promotes Piasy degradation and regulates UVB-induced keratinocyte apoptosis through NFkappaB.
    Albor A; El-Hizawi S; Horn EJ; Laederich M; Frosk P; Wrogemann K; Kulesz-Martin M
    J Biol Chem; 2006 Sep; 281(35):25850-66. PubMed ID: 16816390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PIAS3 enhances the transcriptional activity of HIF-1α by increasing its protein stability.
    Nakagawa K; Kohara T; Uehata Y; Miyakawa Y; Sato-Ueshima M; Okubo N; Asaka M; Takeda H; Kobayashi M
    Biochem Biophys Res Commun; 2016 Jan; 469(3):470-6. PubMed ID: 26697750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SUMOylation of the transcription factor ZFHX3 at Lys-2806 requires SAE1, UBC9, and PIAS2 and enhances its stability and function in cell proliferation.
    Wu R; Fang J; Liu M; A J; Liu J; Chen W; Li J; Ma G; Zhang Z; Zhang B; Fu L; Dong JT
    J Biol Chem; 2020 May; 295(19):6741-6753. PubMed ID: 32249212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SUMOylation of hnRNP-K is required for p53-mediated cell-cycle arrest in response to DNA damage.
    Lee SW; Lee MH; Park JH; Kang SH; Yoo HM; Ka SH; Oh YM; Jeon YJ; Chung CH
    EMBO J; 2012 Nov; 31(23):4441-52. PubMed ID: 23092970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysfunction of the ubiquitin proteasome and ubiquitin-like systems in schizophrenia.
    Rubio MD; Wood K; Haroutunian V; Meador-Woodruff JH
    Neuropsychopharmacology; 2013 Sep; 38(10):1910-20. PubMed ID: 23571678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuronal activity-induced SUMOylation of Akt1 by PIAS3 is required for long-term potentiation of synaptic transmission.
    Meng L; Du CP; Lu CY; Zhang K; Li L; Yan JZ; Hou XY
    FASEB J; 2021 Aug; 35(8):e21769. PubMed ID: 34288124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.